MetaPharm Inc. International is an international contract research organization (CRO) with a proven track record in successfully delivering phase I through phase IV studies in all major indications, including pediatric trials, orphan drugs, biologics, and medical devices, non-interventional studies (NIS), and post-authorization studies. Using our close connections with leading investigators and key opinion leaders, we believe in providing the highest quality solutions worldwide.
For the last 5 years, MetaPharm Inc. has been at the forefront of delivering trials in Women’s Health, focusing on the many unmet medical needs and working to improve existing drug and device therapies in both reproductive health, age-related conditions, and other indications.
ART, e.g. IVF, ICSI
Endometriosis
Contraception
Postmenopausal Complaints
Vulvar and Vaginal Atrophy
Vaginitis
Rheumatoid Arthritis
Fibromyalgia Syndrome (FMS)
Polymyalgia Rheumatica
Oncology
Pain Management
Obstetrics
By utilizing more than two decades of industry experience, coupled with the professional experience of our staff, MetaPharm Inc. provides a well-established approach for successful Women’s Health trials.
Recruitment is pivotal in achieving the desired outcome of a study. The MetaPharm Inc. team is highly experienced in developing therapeutically appropriate and insightful feasibility questionnaires and extrapolating this to our enrollment plans. Our teams recognize that feminine healthcare has considerable variability in different settings across countries and local cultures, thereby requiring sensitivity and local knowledge. MetaPharm Inc. therefore conducts a feasibility survey to confirm projected recruitment rates and utilizes feedback from local Principal Investigators (PI) as part of our standard proposal process.
MetaPharm Inc. project teams are experts in the design and delivery of site training to ensure protocol-consistent enrolment and efficacy assessments, using electronic data capture systems (EDC, eCOA e.g., ePRO) and innovative study tools including our own project management tool.